Follow-The-Filings

Security · featured owners

BBNX Beta Bionics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $9M
  • 1 reduce 1 exit

BBNX (Beta Bionics Inc.) is held in 1 featured 13F book as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (0.04%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management reduce 0.04%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management 2026 Q2 0.04% Reduce −83.5% 595,000 $9M history
First Eagle Investment Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 242,000 $2M history

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Sep 14, 2026 Filing Doc
4 Period Sep 9, 2026 Filing Doc
4 Period Sep 3, 2026 Filing Doc
4 Period Sep 2, 2026 · 5 forms Filing Doc
4/A Period Jun 26, 2026 Filing Doc
4 Period Jun 26, 2026 Filing Doc
4 Period Jun 24, 2026 · 2 forms Filing Doc
4 Period Jun 4, 2026 · 2 forms Filing Doc
4 Period Jun 2, 2026 · 5 forms Filing Doc
4 Period May 21, 2026 · 6 forms Filing Doc

Updated about 1 hour ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $65.12M $100.25M
Gross profit $35.89M $55.54M
Gross margin * 55.1% 55.4%
Net income -$54.76M -$73.2M
Net margin * -84.1% -73.0%

Balance sheet

Metric FY2024 FY2025
Total current assets $132.92M $267.9M
Total non-current assets * $16.72M $60.84M
Total assets $149.64M $328.74M
Total current liabilities $21.15M $30.92M
Total non-current liabilities * $52.48M $10.21M
Total equity -$245.36M $287.61M

Cash flow

Metric FY2024 FY2025
Cash from operations -$48.27M -$50.92M
Cash from investing -$3.48M -$162.8M
Cash from financing $55.62M $214.87M
Net change in cash $3.87M $1.14M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders